Our company
BIC Securities is a leading independent corporate finance advisory firm acting mainly in Russia, Ukraine and the Baltics
Through our network and contacts we are well positioned to execute domestic and cross border equity transactions, primarily mergers & acquisitions (M&A), in our core markets as well as in other countries of Europe and CIS
|
.gif) |
 |
- Russian Federation
- Ukraine
- Baltic States – Latvia, Lithuania and Estonia
- Scandinavian Countries
|
 |
- UK, Germany, France
- Czech Republic, Slovakia, Poland, Hungary, Slovenia, Romania, Bulgaria, Serbia
- Other selected Eastern European and CIS countries
|
|
|
What's new
 |
|
10/04/2019
Creative Mobile, the Estonia-based mobile game developer and publisher, has raised its first capital round from a private investor, allowing the company to expand its game development capacity and streamline its user acquisition...
Read more
|
18/10/2017
Otravo, one of the market leaders in the area of online travel in Northwest Europe is taking over Lithuania-based online travel company Interneto Partneris, allowing Otravo to expand its operations in the Baltic States...
Read more
|
01/09/2017
On September 01, 2017 Takeda Pharmaceuticals (Takeda) (TYO: 4502), a leading pharmaceutical company in Japan and one of the leading companies in Asia and worldwide, completed the acquisition of intellectual property rights for certain OTC and FS products from company Unipharm Inc. (USA), including worldwide rights for Vitrum vitamin brand...
Read more
|
15/05/2017
Amber Beverage Group (ABG), the largest alcohol manufacturer and distributor in the Baltics and part of SPI global group, acquired a significant minority stake in Cellar Trends, allowing the Company to significantly increase its position on the UK market...
Read more
|
05/10/2016
BPM Mezzanine Fund SICAV-SIF, SCA (BPM) has invested in the leading Baltic data center operator DEAC to support its growth...
Read more
|
18/05/2016
Russian Pharmaceutical Forum is the foremost gathering of top management of international and local pharmaceutical producers, distributors and retailers...
Read more
|
01/01/2016
DIOD, Russian pharmaceutical producer has completed the transaction on sale of Orvirem product brand portfolio, including trademarks and other product related IP rights, to Alvogen, a leading international pharmaceutical company...
Read more
|
|
|